Antitumor activity and some pharmacologic properties of anthramycin methyl ether.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D046508:Culture Techniques; D004247:DNA; D003609:Dactinomycin / Q000627:therapeutic use; D004285:Dogs; D004562:Electrocardiography; D006591:Hexobarbital / Q000494:pharmacology; D007939:Leukemia L1210 / Q000188:drug therapy / Q000378:metabolism; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000378:metabolism; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000378:metabolism; D008297:Male; D051379:Mice; D009705:Nucleosides; D012119:Respiration / Q000187:drug effects; D013057:Spectrum Analysis; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014466:Ultraviolet Rays; D014529:Uridine / Q000378:metabolism; D062367:ortho-Aminobenzoates
D000903:Antibiotics, Antineoplastic; D009705:Nucleosides; D062367:ortho-Aminobenzoates; D014316:Tritium; D003609:Dactinomycin; D004247:DNA; D006591:Hexobarbital; D013936:Thymidine; D014529:Uridine